Journal of Affective Disorders
Volume 122, Issue 1 , Pages 27-38, April 2010

Asenapine in the treatment of acute mania in bipolar I disorder: A randomized, double-blind, placebo-controlled trial

  • Roger S. McIntyre

      Affiliations

    • University of Toronto, Toronto, ON, Canada
    • Corresponding Author InformationCorresponding author. University of Toronto, University Health Network, 399 Bathurst Street, MP 9-325, Toronto, ON, Canada M5T 2S8. Tel.: +1 416 603 5279; fax: +1 416 603 5368.
    • ,
  • Miriam Cohen

      Affiliations

    • Merck, Summit, NJ, United States
    • ,
  • Jun Zhao

      Affiliations

    • Merck, Summit, NJ, United States
    • ,
  • Larry Alphs

      Affiliations

    • Employed at Pfizer Global Research and Development, Ann Arbor, MI, United States, at the time of this study
    • ,
  • Thomas A. Macek

      Affiliations

    • Employed at Pfizer Global Research and Development, Ann Arbor, MI, United States, at the time of this study
    • ,
  • John Panagides

      Affiliations

    • Merck, Summit, NJ, United States

Received 13 October 2009; received in revised form 15 December 2009; accepted 29 December 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0165-0327(10)00007-8

doi:10.1016/j.jad.2009.12.028

Journal of Affective Disorders
Volume 122, Issue 1 , Pages 27-38, April 2010

Article Tools

* Image Usage & Resolution